Acadian Asset Management’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-119,020
| Closed | -$361K | – | 1687 |
|
|
2021
Q2 | $361K | Buy |
119,020
+83,717
| +237% | +$254K | ﹤0.01% | 1260 |
|
|
2021
Q1 | $118K | Buy |
+35,303
| New | +$118K | ﹤0.01% | 1635 |
|
|
2014
Q3 | – | Sell |
-5,799
| Closed | -$76K | – | 1045 |
|
|
2014
Q2 | $76K | Sell |
5,799
-72,725
| -93% | -$953K | ﹤0.01% | 887 |
|
|
2014
Q1 | $1.71M | Buy |
78,524
+5,800
| +8% | +$126K | 0.01% | 506 |
|
|
2013
Q4 | $579K | Buy |
+72,724
| New | +$579K | ﹤0.01% | 658 |
|